GE HealthCare Technologies Inc. $GEHC Shares Sold by Evelyn Partners Investment Management Europe Ltd

Evelyn Partners Investment Management Europe Ltd lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 83.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,842 shares of the company’s stock after selling 14,139 shares during the quarter. Evelyn Partners Investment Management Europe Ltd’s holdings in GE HealthCare Technologies were worth $211,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. N.E.W. Advisory Services LLC purchased a new stake in GE HealthCare Technologies during the 1st quarter worth about $25,000. Allianz SE boosted its stake in shares of GE HealthCare Technologies by 165.2% during the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after purchasing an additional 218 shares during the last quarter. Gladwyn Financial Advisors Inc. purchased a new stake in shares of GE HealthCare Technologies during the second quarter worth about $34,000. Game Plan Financial Advisors LLC raised its position in shares of GE HealthCare Technologies by 295.3% in the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after buying an additional 375 shares during the last quarter. Finally, Zions Bancorporation National Association UT purchased a new position in shares of GE HealthCare Technologies during the first quarter valued at approximately $42,000. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $76.45 on Friday. The stock has a market capitalization of $34.82 billion, a P/E ratio of 15.80, a PEG ratio of 3.12 and a beta of 1.13. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The business’s fifty day moving average price is $74.70 and its 200 day moving average price is $73.82. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same period last year, the business posted $1.14 EPS. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Shareholders of record on Friday, October 24th were paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date was Friday, October 24th. GE HealthCare Technologies’s payout ratio is currently 2.89%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on GEHC. Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price target for the company from $93.00 to $83.00 in a report on Tuesday, October 7th. Stifel Nicolaus set a $90.00 price objective on GE HealthCare Technologies in a research report on Friday. Evercore ISI increased their target price on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday. Finally, BTIG Research reaffirmed a “buy” rating and set a $87.00 price objective on shares of GE HealthCare Technologies in a research note on Friday. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $86.45.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.